{"id":182553,"date":"2026-08-04T10:04:47","date_gmt":"2026-08-04T04:34:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=182553"},"modified":"2026-08-04T10:04:47","modified_gmt":"2026-08-04T04:34:47","slug":"glenmark-life-sciences-ltd-share-price-52-week-high-2026-08-04","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/glenmark-life-sciences-ltd-share-price-52-week-high-2026-08-04\/","title":{"rendered":"Glenmark Life Sciences Ltd. (ALIVUS) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;;margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Glenmark Life Sciences Ltd.<\/a> Share Price hits a fresh 52-week high at Rs 1,240, marking a 2.33% rise. Market cap stands at Rs 14,877.44 crore.<\/p>\n<p style=\"margin-top:0!important;;margin-top:0!important;\">Glenmark Life Sciences Ltd. Share Price has reached a fresh 52-week high of Rs 1,240, reflecting a 2.33% increase from the previous close of Rs 1,211.8. This surge in the share price has pushed the company&#8217;s market capitalisation to Rs 14,877.44 crore. The stock opened at Rs 1,229.95 and fluctuated between a low of Rs 1,205.25 and the new high of Rs 1,240 during the trading session. The turnover for the day was Rs 0.22 crore, with a volume of 1,811 shares traded. This price movement highlights the stock&#8217;s strong performance in the market.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Glenmark_Life_Sciences_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glenmark Life Sciences Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,240<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,211.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 28.2 (+2.33%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,229.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,240<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,205.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,811<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.22 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,877.44 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) traded at Rs 1,240. versus the previous close of Rs 1,211.8, a rise of 2.33%. The stock opened at Rs 1,229.95, reached Rs 1,240, touched Rs 1,205.25. Reported volume was 1,811.<\/p>\n<p>Today, Glenmark Life Sciences Ltd. Share Price opened at Rs 1,229.95 and quickly climbed to a fresh 52-week high of Rs 1,240. The stock experienced a day low of Rs 1,205.25 before closing at the new high, marking a 2.33% increase from the previous close of Rs 1,211.8. The turnover for the day was Rs 0.22 crore, with a volume of 1,811 shares, indicating moderate trading activity. This upward movement in the share price suggests a positive sentiment among investors.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Glenmark_Life_Sciences_Ltd_ALIVUS_Fundamental_Analysis\"><\/span><strong>Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,877.44 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. was valued at a P\/E ratio of 39.39x, a P\/B ratio of 7.98x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.89x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">73.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,364.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.92%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,877.44 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 139.24 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) is classified under sector: Healthcare.<\/p>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a P\/E ratio of 39.39x, which is above the benchmark median of 20.89x, a difference of +88.56%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a ROE of 28.21%, which is above the benchmark median of 10.92%, a difference of +158.33%. Glenmark Life Sciences Ltd. (ALIVUS) has a ROCE of 26.35%, which is above the benchmark median of 13.29%, a difference of +98.27%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,683.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,474.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,421.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,416.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">171.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hesterbio\/hester-biosciences-ltd-share-price-today\"><strong>Hester Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HESTERBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,111.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.12<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a P\/E ratio of 39.39x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Glenmark Life Sciences Ltd. (ALIVUS) has a market capitalisation of Rs 14,877.44 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glenmark_Life_Sciences_Ltd\"><\/span><strong>Why Investors Are Watching Glenmark Life Sciences Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glenmark Life Sciences Ltd. Share Price reached a fresh 52-week high, indicating strong market interest.<\/li>\n<li>The company&#8217;s valuation metrics suggest a premium position within the sector.<\/li>\n<li>High ROE and ROCE highlight efficient management and profitability.<\/li>\n<li>Significant market capitalisation compared to peers.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Glenmark_Life_Sciences_Ltd\"><\/span><strong>About Glenmark Life Sciences Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Life Sciences Ltd. is a prominent player in the Healthcare sector, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs). The company caters to a diverse range of therapeutic segments, including cardiovascular, central nervous system, and dermatology. With a strong emphasis on research and development, Glenmark Life Sciences Ltd. aims to deliver high-quality and cost-effective pharmaceutical solutions. Its robust market presence and strategic partnerships have positioned it as a key player in the pharmaceutical industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Glenmark_Life_Sciences_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Glenmark Life Sciences Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Glenmark Life Sciences Ltd. (ALIVUS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors can track Glenmark Life Sciences Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay informed with the latest data and analysis to make well-informed investment decisions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What is the current share price of Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Glenmark Life Sciences Ltd. is Rs 1,240, marking a fresh 52-week high with a 2.33% increase from the previous close. The stock moved 2.33% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Life_Sciences_Ltds_PE_ratio_compare_to_the_sector\"><\/span><strong>How does Glenmark Life Sciences Ltd.&#39;s P\/E ratio compare to the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd.&#39;s P\/E ratio of 39.39 is higher than the sector median of 20.89, indicating a relatively expensive valuation compared to peers. The company trades at a P\/E ratio of 39.39x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What is the market capitalisation of Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd. has a market capitalisation of Rs 14,877.44 crore, reflecting its significant size within the Healthcare sector. The company operates in the Healthcare sector. Its P\/E ratio is 39.39x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Life_Sciences_Ltds_ROE_compare_to_the_sector\"><\/span><strong>How does Glenmark Life Sciences Ltd.&#39;s ROE compare to the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd.&#39;s ROE of 28.21% is significantly higher than the sector median of 10.92%, showcasing strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PB_ratio_of_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What is the P\/B ratio of Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/B ratio of Glenmark Life Sciences Ltd. is 7.98, which is above the sector median of 1.9, indicating a premium valuation. The company trades at a P\/E ratio of 39.39x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Life_Sciences_Ltds_ROCE_compare_to_the_sector\"><\/span><strong>How does Glenmark Life Sciences Ltd.&#39;s ROCE compare to the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd.&#39;s ROCE of 26.35% is well above the sector median of 13.29%, highlighting efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_peers_are_compared_with_Glenmark_Life_Sciences_Ltd\"><\/span><strong>Which peers are compared with Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Peers compared include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye Hospital Ltd., Sai Parenteral&#39;s Ltd., and Hester Biosciences Ltd. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye Hospital Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_significance_of_Glenmark_Life_Sciences_Ltds_52-week_high\"><\/span><strong>What is the significance of Glenmark Life Sciences Ltd.&#39;s 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52-week high of Rs 1,240 indicates strong market interest and positive investor sentiment towards Glenmark Life Sciences Ltd. The stock moved 2.33% during the session. The intraday range extended from Rs 1,205.25 to Rs 1,240.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Life Sciences Ltd. Share Price hits a new 52-week high at Rs 1,240. marking a 2.33% rise today. Market cap stands at Rs 14,877.44 crore.<\/p>\n","protected":false},"author":29,"featured_media":182552,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-182553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["182552"],"rank_math_title":["Glenmark Life Sciences Ltd. Stock Reaches New 52-Week High"],"rank_math_description":["Glenmark Life Sciences Ltd. Share Price hits a fresh 52-week high at Rs 1,240. Explore price action, fundamentals, and sector analysis for insights."],"rank_math_focus_keyword":["Glenmark Life Sciences Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Glenmark_Life_Sciences_Ltd_ALIVUS_Share_Price_Hits_Fresh_52_Week_High_bullish-1.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/182553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=182553"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/182553\/revisions"}],"predecessor-version":[{"id":182554,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/182553\/revisions\/182554"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/182552"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=182553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=182553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=182553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}